June 10, 2024

US Liquid Biopsy Market Size to Grow US$ 1,816.95 Million By 2032

The US liquid biopsy market size was approximate at US$ 362.82 million in 2022 and is anticipated to grow US$ 1,816.95 million by 2032, registering a compound annual growth rate of 17.48% from 2022 to 2032.

US Liquid Biopsy Market Size 2023 To 2032

The US liquid biopsy market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the US liquid biopsy market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the US liquid biopsy report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the US liquid biopsy market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2474

US Liquid Biopsy Market  Report Scope 

Report Coverage Details
Market Size in 2022 USD 362.82 Million
Market Size by 2032 USD 1,816.95 Million
Growth Rate from 2023 to 2032 CAGR of 17.48%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Biomarker Types, By Application, By Sample, By End User

Also read: Tissue Diagnostics Market Size to Grow US$ 122.74 Billion By 2032

Research Approach

The comprehensive report on the global US liquid biopsy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global US liquid biopsy market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

  • ANGLE plc, Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Epigenomics AG
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Guardant Health Inc.
  • Illumina Inc.
  • MDxHealth SA
  • Menarini Silicon Biosystems
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

US Liquid Biopsy Market Segmentations

By Biomarker Types 

  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (CTDNA)
  • Extracellular vesicles (EVS)
  • Other Biomarkers

By Application 

  • Cancer Therapeutic Application
  • Reproductive Health
  • Other Therapeutic Application

By Sample 

  • Blood Sample
  • Urine Sample
  • Other

By End User 

  • Hospitals and Laboratories
  • Academic and Research Centers
  • Other End Users

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Liquid Biopsy Market 

5.1. COVID-19 Landscape: US Liquid Biopsy Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Liquid Biopsy Market, By Biomarker Types

8.1. US Liquid Biopsy Market, by Biomarker Types, 2023-2032

8.1.1. Circulating Tumor Cells (CTCs)

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Circulating Tumor DNA (CTDNA)

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Extracellular vesicles (EVS)

8.1.3.1. Market Revenue and Forecast (2023-2032)

8.1.4. Other Biomarkers

8.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 9. US Liquid Biopsy Market, By Application

9.1. US Liquid Biopsy Market, by Application, 2023-2032

9.1.1. Cancer Therapeutic Application

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Reproductive Health

9.1.2.1. Market Revenue and Forecast (2023-2032)

9.1.3. Other Therapeutic Application

9.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 10. US Liquid Biopsy Market, By Sample 

10.1. US Liquid Biopsy Market, by Sample, 2023-2032

10.1.1. Blood Sample

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Urine Sample

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Other

10.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 11. US Liquid Biopsy Market, By End User 

11.1. US Liquid Biopsy Market, by End User, 2023-2032

11.1.1. Hospitals and Laboratories

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Academic and Research Centers

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Other End Users

11.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 12. US Liquid Biopsy Market, Regional Estimates and Trend Forecast

12.1. U.S.

12.1.1. Market Revenue and Forecast, by Biomarker Types (2023-2032)

12.1.2. Market Revenue and Forecast, by Application (2023-2032)

12.1.3. Market Revenue and Forecast, by Sample (2023-2032)

12.1.4. Market Revenue and Forecast, by End User (2023-2032)

Chapter 13. Company Profiles

13.1. ANGLE plc, Biocept Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bio-Rad Laboratories Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Epigenomics AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Exact Sciences Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. F. Hoffmann-La Roche AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Guardant Health Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Illumina Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. MDxHealth SA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Menarini Silicon Biosystems

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. QIAGEN N.V.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global US liquid biopsy market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for US liquid biopsy are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

 

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *